PSILAdvisorShares Psychedelics ETF
Issuer： AdvisorShares· Type： ETF
Positioning： Growth
Underlying exposure
Companies involved in psychedelic medicines, biotechnology, mental health treatments, and related healthcare research.
Strategy brief
Actively managed thematic ETF investing in companies with exposure to psychedelic and mental health treatment innovation.
Latest close
$25.15
(+3.41%)
As of 2026-09-17
Latest distribution
$1.68
Ex-date 2025-12-22
Estimated forward yield
36.19%
Listed date
2021-09-15
Expense ratio
1.00%
Payout frequency
Quarterly